Corcept Therapeutics
CORT
$25.06
Share price
4.94%
Change (1 day)
11.92%
Change (1 year)
Categories
Corcept Therapeutics (CORT) - Total assets
Total assets on the balance sheet as of December 2023 : $0.62 B
According to Corcept Therapeutics 's latest financial reports the company's total assets are $0.62 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Corcept Therapeutics - Total assets on balance sheet (from 2003 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.62 B | 6.53% |
| 2022-12-31 | $0.58 B | 37.68% |
| 2021-12-31 | $0.42 B | -25.88% |
| 2020-12-31 | $0.57 B | 38.66% |
| 2019-12-31 | $0.41 B | 32.28% |
| 2018-12-31 | $0.31 B | 41.33% |
| 2017-12-31 | $0.22 B | 220.77% |
| 2016-12-31 | $68.75 M | 32.47% |
| 2015-12-31 | $51.9 M | 49.88% |
| 2014-12-31 | $34.63 M | -45.1% |
| 2013-12-31 | $63.07 M | -36.39% |
| 2012-12-31 | $99.16 M | 148.95% |
| 2011-12-31 | $39.83 M | 58.67% |
| 2010-12-31 | $25.1 M | 2.42% |
| 2009-12-31 | $24.51 M | 23.95% |
| 2008-12-31 | $19.77 M | 11.45% |
| 2007-12-31 | $17.74 M | 79.2% |
| 2006-12-31 | $9.9 M | -67.16% |
| 2005-12-31 | $30.15 M | -36.88% |
| 2004-12-31 | $47.77 M | 305.5% |
| 2003-12-31 | $11.78 M | -45.95% |
| 2002-12-31 | $21.79 M | -10.16% |
| 2001-12-31 | $24.25 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 26,859.52% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 15,078.02% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 36,343.25% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 10,198.40% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 17,063.65% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 15,833.76% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.47 B | -23.54% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.20 B | -66.89% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 1,000.79% | 🇺🇸 USA |